Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S ALEXANDER

Showing results (1421-1430 of 1,467) with videos related to

Pageof 147
Sort By:
Nucleic Acids Research|November 6, 2018
Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humansJarny Choi, Tracey M Baldwin, Mae Wong, et al.
Neuroimage|July 1, 2020
Brain extraction on MRI scans in presence of diffuse glioma: Multi-institutional performance evaluation of deep learning methods and robust modality-agnostic trainingSiddhesh Thakur, Jimit Doshi, Sarthak Pati, et al.
Nature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.
Blood|July 28, 2018
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AMLMathijs A Sanders, Edward Chew, Christoffer Flensburg, et al.
The American Journal of Hospice & Palliative Care|August 28, 2020
Early Use of the Palliative Approach to Improve Patient Outcomes in HIV Disease: Insights and Findings From the Care and Support Access (CASA) Study 2013-2019Carla S Alexander, Victoria H Raveis, Daniel Karus, et al.
Journal of Medicinal Chemistry|December 4, 2003
Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1)James R Pruitt, Donald J P Pinto, Robert A Galemmo, et al.
Journal of Leukocyte Biology|October 26, 1999
Suppressors of cytokine signaling (SOCS): negative regulators of signal transductionW S Alexander, R Starr, D Metcalf, et al.
Blood|March 17, 2023
Iron homeostasis governs erythroid phenotype in polycythemia veraCavan Bennett, Victoria E Jackson, Anne Pettikiriarachchi, et al.
Journal of Medicinal Chemistry|October 3, 2003
Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulantsPatrick Y S Lam, Charles G Clark, Renhua Li, et al.
Plos Neglected Tropical Diseases|January 7, 2022
Mapping environmental suitability of Haemagogus and Sabethes spp. mosquitoes to understand sylvatic transmission risk of yellow fever virus in BrazilSabrina L Li, André L Acosta, Sarah C Hill, et al.
Pageof 147

Showing results (1421-1430 of 1,467) with videos related to

Sort By:
Pageof 147
Nucleic Acids Research|November 6, 2018
Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humansJarny Choi, Tracey M Baldwin, Mae Wong, et al.
Neuroimage|July 1, 2020
Brain extraction on MRI scans in presence of diffuse glioma: Multi-institutional performance evaluation of deep learning methods and robust modality-agnostic trainingSiddhesh Thakur, Jimit Doshi, Sarthak Pati, et al.
Nature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.
Blood|July 28, 2018
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AMLMathijs A Sanders, Edward Chew, Christoffer Flensburg, et al.
The American Journal of Hospice & Palliative Care|August 28, 2020
Early Use of the Palliative Approach to Improve Patient Outcomes in HIV Disease: Insights and Findings From the Care and Support Access (CASA) Study 2013-2019Carla S Alexander, Victoria H Raveis, Daniel Karus, et al.
Journal of Medicinal Chemistry|December 4, 2003
Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1)James R Pruitt, Donald J P Pinto, Robert A Galemmo, et al.
Journal of Leukocyte Biology|October 26, 1999
Suppressors of cytokine signaling (SOCS): negative regulators of signal transductionW S Alexander, R Starr, D Metcalf, et al.
Blood|March 17, 2023
Iron homeostasis governs erythroid phenotype in polycythemia veraCavan Bennett, Victoria E Jackson, Anne Pettikiriarachchi, et al.
Journal of Medicinal Chemistry|October 3, 2003
Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulantsPatrick Y S Lam, Charles G Clark, Renhua Li, et al.
Plos Neglected Tropical Diseases|January 7, 2022
Mapping environmental suitability of Haemagogus and Sabethes spp. mosquitoes to understand sylvatic transmission risk of yellow fever virus in BrazilSabrina L Li, André L Acosta, Sarah C Hill, et al.
Pageof 147